Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.
2.

Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.

Zhou XY, Yashiro-Ohtani Y, Nakahira M, Park WR, Abe R, Hamaoka T, Naramura M, Gu H, Fujiwara H.

J Immunol. 2002 Apr 15;168(8):3847-54.

3.

Signals from CD28 induce stable epigenetic modification of the IL-2 promoter.

Thomas RM, Gao L, Wells AD.

J Immunol. 2005 Apr 15;174(8):4639-46.

4.

Acetylation of cAMP-responsive element-binding protein (CREB) by CREB-binding protein enhances CREB-dependent transcription.

Lu Q, Hutchins AE, Doyle CM, Lundblad JR, Kwok RP.

J Biol Chem. 2003 May 2;278(18):15727-34. Epub 2003 Feb 20.

6.

C/EBPbeta activates E2F-regulated genes in vivo via recruitment of the coactivator CREB-binding protein/P300.

Wang H, Larris B, Peiris TH, Zhang L, Le Lay J, Gao Y, Greenbaum LE.

J Biol Chem. 2007 Aug 24;282(34):24679-88. Epub 2007 Jun 27.

7.

CD28 signaling augments Elk-1-dependent transcription at the c-fos gene during antigen stimulation.

Li W, Whaley CD, Bonnevier JL, Mondino A, Martin ME, Aagaard-Tillery KM, Mueller DL.

J Immunol. 2001 Jul 15;167(2):827-35.

8.
9.

HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.

Wong K, Sharma A, Awasthi S, Matlock EF, Rogers L, Van Lint C, Skiest DJ, Burns DK, Harrod R.

J Biol Chem. 2005 Mar 11;280(10):9390-9. Epub 2004 Dec 15.

10.

Histone modifications in kainate-induced status epilepticus.

Sng JC, Taniura H, Yoneda Y.

Eur J Neurosci. 2006 Mar;23(5):1269-82.

PMID:
16553789
11.

Identification of a CD28 response element in the CD40 ligand promoter.

Parra E, Mustelin T, Dohlsten M, Mercola D.

J Immunol. 2001 Feb 15;166(4):2437-43.

12.
13.

Cloning and characterization of ALX, an adaptor downstream of CD28.

Greene TA, Powell P, Nzerem C, Shapiro MJ, Shapiro VS.

J Biol Chem. 2003 Nov 14;278(46):45128-34. Epub 2003 Sep 5.

14.

Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.

Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML, Koseki H, Kitabayashi I.

EMBO J. 2006 Sep 6;25(17):3955-65. Epub 2006 Aug 17.

15.

Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP.

Vervoorts J, Lüscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, Austen M, Lüscher B.

EMBO Rep. 2003 May;4(5):484-90.

16.

Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells.

Butscher WG, Haggerty CM, Chaudhry S, Gardner K.

J Biol Chem. 2001 Jul 20;276(29):27647-56. Epub 2001 Apr 19.

17.

Coactivator CBP in the regulation of conceptus IFNtau gene transcription.

Xu N, Takahashi Y, Matsuda F, Sakai S, Christenson RK, Imakawa K.

Mol Reprod Dev. 2003 May;65(1):23-9.

PMID:
12658630
18.

Differential regulation of proto-oncogenes c-jun and c-fos in T lymphocytes activated through CD28.

Chatta GS, Spies AG, Chang S, Mize GJ, Linsley PS, Ledbetter JA, Morris DR.

J Immunol. 1994 Dec 15;153(12):5393-401.

PMID:
7989745
19.

Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells.

Fonte C, Grenier J, Trousson A, Chauchereau A, Lahuna O, Baulieu EE, Schumacher M, Massaad C.

Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14260-5. Epub 2005 Sep 26.

20.

Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.

Shen HY, Kalda A, Yu L, Ferrara J, Zhu J, Chen JF.

Neuroscience. 2008 Dec 2;157(3):644-55. doi: 10.1016/j.neuroscience.2008.09.019. Epub 2008 Sep 16.

PMID:
18848971

Supplemental Content

Support Center